List of Oncology APIs

640
List of oncology APIs
List of Oncology APIs
5 (100%) 9 votes

List of oncology APIs

Here is the list of oncology APIs for finished products circulating in the world

Please to provide us more APIs in case not up to date, vnras.com@gmail.com

List from Alex Chung

For more full list of oncology medicine granted registration numbers circulating in Vietnam.

UPDATED APRIL 27, 2018

DCI Classification Vietnam
5-fluorouracile *
Abiraterone  *
Afatinib *
Aflibercept
Alemtuzumab (CD52, lymphocytes B et T) Monoclonal antibodies against lymphocytes (target in parentheses)
Altretamine Other compounds
Amsacrine
Anastrozol Hormonal antagonists and aromatase inhibitors *
Axitinib
Azacitidine Pyrimidine analogs
Azathioprime Purine analogs and related inhibitors
BCG lyophilise Modulators of the host response
Bendamustine *
Bevacizumab Monoclonal antibodies against VEGF
Bexarotene
Bicalutamid Hormonal antagonists and aromatase inhibitors *
Bleomycine *
Bortezomib *
Bosutinib
Brentuximab vedotin
Busereline Hormonal antagonists and aromatase inhibitors
Busulfan Nitrogen Mustards *
Cabazitaxel
Capecitabine Pyrimidine analogs *
Carboplatine Platinum coordination complexes *
Carmustine Nitrosoureas
Catumaxomab (CD3, lymphocytes B) Monoclonal antibodies against lymphocytes (target in parentheses)
Cetuximab (EGFR, HER1) Monoclonal antibodies to HER receptors (target in parentheses)
Chlorambucil Nitrogen Mustards
Chlormethine Nitrogen Mustards
Cisplatine Platinum coordination complexes *
Cladribine Purine analogs and related inhibitors
Clofarabine Purine analogs and related inhibitors
Crizotinib
Cyclophosphamide Nitrogen Mustards *
Cyproterone Hormonal antagonists and aromatase inhibitors *
Cytarabine Pyrimidine analogs *
Dabrafenib
Dacarbazine Other compounds
Dactinomycine
Dasatinib (Bcr-Abl) Tyrosines kinases inhibitors (target in parentheses)
Daunorubicine Anthracyclines *
Daunorubicine liposomale *
Decitabine *
Degarelix Hormonal antagonists and aromatase inhibitors *
Diethylstilbestrol Hormonal antagonists and aromatase inhibitors
Docetaxel Alkaloids of l’If (taxanes) *
Doxorubicine Anthracyclines *
Doxorubicine liposomale *
Doxorubicine liposomale pegylee *
Epirubicine Anthracyclines *
Eribuline
Erlotinib (HER1) Tyrosines kinases inhibitors (target in parentheses) *
Estramustine Other compounds
Etoposide topoisomérase II inhibitors *
Etoposide phosphate
Everolimus mTOR kinase inhibitors *
Exemestane Hormonal antagonists and aromatase inhibitors *
Fludarabine Purine analogs and related inhibitors *
Fluororuracile (5-FU) Pyrimidine analogs
Flutamide Hormonal antagonists and aromatase inhibitors
Fotemustine Nitrosoureas
Fulvestrant Hormonal antagonists and aromatase inhibitors *
Gefitinib (HER1) Tyrosines kinases inhibitors (target in parentheses) *
Gemcitabine Pyrimidine analogs *
Gosereline Hormonal antagonists and aromatase inhibitors *
Hydroxycarbamide
Hydroxyuree (hydroxycarbamide) Other compounds *
Ibritumomab (CD2, lymphocytes B) Monoclonal antibodies against lymphocytes (target in parentheses)
Idarubicine Anthracyclines *
Ifosfamide Nitrogen Mustards *
Imatinib (Bcr-Abl) Tyrosines kinases inhibitors (target in parentheses) *
Interferon-α (IFN-α) Modulators of the host response
Interleukine-2 (IL-2) Modulators of the host response
Ipilimumab
Irinotecan  Topoisomérase I inhibitors *
Lanreotide Hormonal antagonists and aromatase inhibitors
Lapatinib (HER1/HER2) Tyrosines kinases inhibitors (target in parentheses) *
L-Asparaginase
Lenalidomide *
Letrozole Hormonal antagonists and aromatase inhibitors *
Leuprorelin acetate Hormonal antagonists and aromatase inhibitors *
Lomustine Nitrosoureas
Medroxyprogesterone Hormonal antagonists and aromatase inhibitors *
Megestrol Hormonal antagonists and aromatase inhibitors
Melphalan Nitrogen Mustards
Mercaptopurine Purine analogs and related inhibitors
Mesna *
Methotrexate Antifolic acid analogs *
Mitomycine C Other compounds
Mitoxantrone Anthracenedione antineoplastic agent *
Nab paclitaxel
Nelarabine Purine analogs and related inhibitors
Nilotinib (Bcr-Abl) Tyrosines kinases inhibitors (target in parentheses) *
Nilutamide Hormonal antagonists and aromatase inhibitors
Octreotide Hormonal antagonists and aromatase inhibitors *
Ofatumumab
Oxaliplatine Platinum coordination complexes *
Paclitaxel Alkaloids of l’If (taxanes) *
Panitumumab (EGFR, HER1) Monoclonal antibodies to HER receptors (target in parentheses)
Pazopanib *
Pemetrexed Antifolic acid analogs *
Pentostatine Purine analogs and related inhibitors
Pertuzumab
Pipobroman Other compounds
Pirarubicine Anthracyclines
Pomalidomide
Ponatinib
Procarbazine Other compounds
Raltitrexed
Regorafenib *
Rituximab (CD20, lymphocytes B) Monoclonal antibodies against lymphocytes (target in parentheses)
Ruxolitinib *
Sorafenib (multikinases) Tyrosines kinases inhibitors (target in parentheses) *
Streptozocine Nitrosoureas
Sunitinib (multikinases) Tyrosines kinases inhibitors (target in parentheses) *
Tamoxifene Hormonal antagonists and aromatase inhibitors *
Tegafur 25mg; Gimeracil 7,25mg; Oteracil kali 24,5mg *
Tegafur-uracile Pyrimidine analogs *
Temozolomide Other compounds *
Temsirolimus mTOR kinase inhibitors
Thalidomide *
Thioguanine
Thiotepa Other compounds
Topotecan Topoisomérase I inhibitors *
Toremifene Hormonal antagonists and aromatase inhibitors
Trabectedine Other compounds
Trastuzumab (HER2) Monoclonal antibodies to HER receptors (target in parentheses)
Tretinoine *
Trioxyde d’arsenic
Triptoreline Hormonal antagonists and aromatase inhibitors *
Vandetanib
Vemurafenib
Vinblastine Alkaloids of Pervenche
Vincristine Alkaloids of Pervenche *
Vindesine Alkaloids of Pervenche
Vinflunine
Vinorelbine Alkaloids of Pervenche *
Vismodegib

LEAVE A REPLY

Please enter your comment!
Please enter your name here